A detailed history of Royal Bank Of Canada transactions in Valneva Se stock. As of the latest transaction made, Royal Bank Of Canada holds 18 shares of VALN stock, worth $114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 18 -0.0%
Holding current value
$114
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$6.64 - $10.76 $13 - $21
-2 Reduced 10.0%
18 $0
Q4 2022

Feb 14, 2023

SELL
$10.38 - $14.87 $20 - $29
-2 Reduced 9.09%
20 $0
Q3 2022

Nov 14, 2022

SELL
$9.8 - $23.35 $215 - $513
-22 Reduced 50.0%
22 $0
Q2 2022

Aug 15, 2022

BUY
$13.71 - $37.57 $603 - $1,653
44 New
44 $1,000
Q1 2022

May 16, 2022

SELL
$27.0 - $50.99 $594 - $1,121
-22 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$27.1 - $67.28 $596 - $1,480
22 New
22 $1,000

Others Institutions Holding VALN

About Valneva SE


  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $441M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.